| 产品编号 | D53665 |
| 英文名称 | PCSK9-IN-10 |
| 中文名称 | |
| 克 隆 号 | |
| CAS | 368434-98-4 |
| 理论分子量 | 373.41 kDa |
| 保存条件 | Powder: -20℃ for 3 years | In solvent: -80℃ for 1 year |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 |
PCSK9-IN-10 is a potent and orally active inhibitor of PCSK9, (IC50: 6.4 µM).PCSK9-IN-10 increases LDLR protein expression and decreases PCSK9 expression.PCSK9-IN-10 slows the progression of atherosclerosis.PCSK9-IN-10 has the potential to investigate hyperlipidemia.CSK9 -IN-10 significantly decreased protein expression and increased LDLR receptor expression in a dose-dependent manner.PCSK9-IN-10 showed low cytotoxicity against HepG2, inhibited liver and serum PCSK9 levels, and reduced atherosclerotic plaque size. |
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
